135 results
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
8 May 24
Dynavax Reports First Quarter 2024 Financial Results
4:05pm
developing and commercializing innovative vaccines, today reported financial results and provided a business update for the quarter ended March 31, 2024 … %).
About Dynavax
Dynavax is a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines to help protect
8-K
EX-99.1
DVAX
Dynavax Technologies Corp.
22 Feb 24
Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results
4:05pm
: DVAX), a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today reported financial results … innovative vaccines to help protect the world against infectious diseases. The Company has two commercial products, HEPLISAV-B® vaccine [Hepatitis B
8-K
EX-99.2
5b7er9iy hkjjs80bjw
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
8-K
EX-99.1
s80ab8uhnben5myuwj
8 Jan 24
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
9:05am
8-K
EX-99.1
tfsxa0ruhf4p8g
2 Nov 23
Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:10pm
S-3ASR
7xkf v6zu
3 Aug 23
Automatic shelf registration
5:26pm
8-K
EX-99.1
zbpoh3268w7g
3 Aug 23
Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
4:11pm
8-K
EX-99.1
3us30bd6n 5hv
2 May 23
Dynavax Reports First Quarter 2023 Financial Results
4:11pm
8-K
EX-99.1
18i35bap53tt6 vt
3 Nov 22
Dynavax Reports Third Quarter 2022 Financial Results
4:10pm
8-K
EX-99.1
msmcshl
4 Aug 22
Dynavax Reports Second Quarter 2022 Financial Results
4:09pm
8-K
EX-99.1
6ax9l w1d9
5 May 22
Dynavax Reports First Quarter 2022 Financial Results
4:04pm